{"id":39724,"date":"2026-07-27T15:07:40","date_gmt":"2026-07-27T19:07:40","guid":{"rendered":"https:\/\/www.cancerresearch.org\/?post_type=cri_scientists&#038;p=39724"},"modified":"2026-07-27T15:07:40","modified_gmt":"2026-07-27T19:07:40","slug":"joseph-palmeri-phd-2","status":"publish","type":"cri_scientists","link":"https:\/\/www.cancerresearch.org\/es\/cri-funded-scientists\/joseph-palmeri-phd-2","title":{"rendered":"Joseph Palmeri, PhD"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Artificial intelligence is rapidly transforming cancer drug development by enabling scientists to design entirely new protein-based therapies. Among the most promising are tiny engineered proteins called \u201cminibinders,\u201d which can direct the immune system to recognize and destroy tumors. However, a major unanswered question remains: will the human immune system mistakenly recognize these AI-designed proteins as foreign and reject them?&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Dr. Palmeri is an immunoengineer focused on developing next-generation cancer immunotherapies. During his doctoral work at MIT, he engineered innovative antibody therapies that remained anchored within tumors, improving anti-cancer activity while reducing dangerous side effects. His research also uncovered important mechanisms controlling T cell activation inside tumors.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In his research, he will investigate the safety of AI-designed protein therapies by studying what makes them immunogenic \u2014 capable of triggering unwanted immune reactions. Using computational protein design, cell culture systems, and mouse models, Dr. Palmeri will engineer variants of AI-designed proteins containing different immune-triggering features and determine how their structural stability influences immune recognition.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The goal is to uncover the rules that determine whether the body views these proteins as safe or foreign. This knowledge could help scientists design future AI-generated cancer therapies that are both highly effective and \u201cimmunologically silent,\u201d reducing side effects while improving long-term treatment success. As AI-designed medicines move closer to clinical use, this work could play a critical role in ensuring their safe introduction into patients.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Mentor<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Caleb Lareau, PhD<\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Projects and Grants<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong><strong>Interrogating the immunogenicity of de novo AI-designed protein minibinder therapeutics<\/strong><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Artificial intelligence is rapidly transforming cancer drug development by enabling scientists to design entirely new protein-based therapies. Among the most promising are tiny engineered proteins called \u201cminibinders,\u201d which can direct the immune [&hellip;]<\/p>\n","protected":false},"featured_media":39716,"template":"","tax_cancer_type":[455],"tax_grant_type":[889],"tax_award_year":[881],"tax_institutions":[493],"tax_location_states":[494],"class_list":["post-39724","cri_scientists","type-cri_scientists","status-publish","has-post-thumbnail","hentry"],"acf":{"scientist_subhead":"CRI Immuno-Informatics Postdoctoral Fellow","quote":"","scientist_last_name":"Palmeri","show_on_landing":true,"scientist_publish_until":"20290727"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Joseph Palmeri, PhD - Cancer Research Institute<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/joseph-palmeri-phd-2\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Joseph Palmeri, PhD - Cancer Research Institute\" \/>\n<meta property=\"og:description\" content=\"Artificial intelligence is rapidly transforming cancer drug development by enabling scientists to design entirely new protein-based therapies. Among the most promising are tiny engineered proteins called \u201cminibinders,\u201d which can direct the immune [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/joseph-palmeri-phd-2\" \/>\n<meta property=\"og:site_name\" content=\"Cancer Research Institute\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2026\/07\/Joseph_Palmeri_Edit@2x.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"1228\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cancerresearch.org\\\/cri-funded-scientists\\\/joseph-palmeri-phd-2\",\"url\":\"https:\\\/\\\/www.cancerresearch.org\\\/cri-funded-scientists\\\/joseph-palmeri-phd-2\",\"name\":\"Joseph Palmeri, PhD - Cancer Research Institute\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cancerresearch.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.cancerresearch.org\\\/cri-funded-scientists\\\/joseph-palmeri-phd-2#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cancerresearch.org\\\/cri-funded-scientists\\\/joseph-palmeri-phd-2#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cancerresearch.org\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Joseph_Palmeri_Edit@2x.webp\",\"datePublished\":\"2026-07-27T19:07:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cancerresearch.org\\\/cri-funded-scientists\\\/joseph-palmeri-phd-2#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cancerresearch.org\\\/cri-funded-scientists\\\/joseph-palmeri-phd-2\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.cancerresearch.org\\\/cri-funded-scientists\\\/joseph-palmeri-phd-2#primaryimage\",\"url\":\"https:\\\/\\\/www.cancerresearch.org\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Joseph_Palmeri_Edit@2x.webp\",\"contentUrl\":\"https:\\\/\\\/www.cancerresearch.org\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Joseph_Palmeri_Edit@2x.webp\",\"width\":1536,\"height\":1228,\"caption\":\"Joseph Palmeri\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cancerresearch.org\\\/cri-funded-scientists\\\/joseph-palmeri-phd-2#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.cancerresearch.org\\\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Joseph Palmeri, PhD\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cancerresearch.org\\\/#website\",\"url\":\"https:\\\/\\\/www.cancerresearch.org\\\/\",\"name\":\"Cancer Research Institute\",\"description\":\"For a World Immune to Cancer\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.cancerresearch.org\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cancerresearch.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.cancerresearch.org\\\/#organization\",\"name\":\"Cancer Research Institute\",\"url\":\"https:\\\/\\\/www.cancerresearch.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.cancerresearch.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.cancerresearch.org\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/logo-gradient.svg\",\"contentUrl\":\"https:\\\/\\\/www.cancerresearch.org\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/logo-gradient.svg\",\"width\":156,\"height\":53,\"caption\":\"Cancer Research Institute\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cancerresearch.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Joseph Palmeri, PhD - Cancer Research Institute","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/joseph-palmeri-phd-2","og_locale":"es_ES","og_type":"article","og_title":"Joseph Palmeri, PhD - Cancer Research Institute","og_description":"Artificial intelligence is rapidly transforming cancer drug development by enabling scientists to design entirely new protein-based therapies. Among the most promising are tiny engineered proteins called \u201cminibinders,\u201d which can direct the immune [&hellip;]","og_url":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/joseph-palmeri-phd-2","og_site_name":"Cancer Research Institute","og_image":[{"width":1536,"height":1228,"url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2026\/07\/Joseph_Palmeri_Edit@2x.webp","type":"image\/webp"}],"twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/joseph-palmeri-phd-2","url":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/joseph-palmeri-phd-2","name":"Joseph Palmeri, PhD - Cancer Research Institute","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/joseph-palmeri-phd-2#primaryimage"},"image":{"@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/joseph-palmeri-phd-2#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2026\/07\/Joseph_Palmeri_Edit@2x.webp","datePublished":"2026-07-27T19:07:40+00:00","breadcrumb":{"@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/joseph-palmeri-phd-2#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cancerresearch.org\/cri-funded-scientists\/joseph-palmeri-phd-2"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/joseph-palmeri-phd-2#primaryimage","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2026\/07\/Joseph_Palmeri_Edit@2x.webp","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2026\/07\/Joseph_Palmeri_Edit@2x.webp","width":1536,"height":1228,"caption":"Joseph Palmeri"},{"@type":"BreadcrumbList","@id":"https:\/\/www.cancerresearch.org\/cri-funded-scientists\/joseph-palmeri-phd-2#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cancerresearch.org\/es"},{"@type":"ListItem","position":2,"name":"Joseph Palmeri, PhD"}]},{"@type":"WebSite","@id":"https:\/\/www.cancerresearch.org\/#website","url":"https:\/\/www.cancerresearch.org\/","name":"Cancer Research Institute","description":"For a World Immune to Cancer","publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cancerresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cancerresearch.org\/#organization","name":"Cancer Research Institute","url":"https:\/\/www.cancerresearch.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","width":156,"height":53,"caption":"Cancer Research Institute"},"image":{"@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/"}}]}},"fimg_url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2026\/07\/Joseph_Palmeri_Edit@2x.webp","_links":{"self":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_scientists\/39724","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_scientists"}],"about":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/types\/cri_scientists"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media\/39716"}],"wp:attachment":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media?parent=39724"}],"wp:term":[{"taxonomy":"tax_cancer_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tax_cancer_type?post=39724"},{"taxonomy":"tax_grant_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tax_grant_type?post=39724"},{"taxonomy":"tax_award_year","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tax_award_year?post=39724"},{"taxonomy":"tax_institutions","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tax_institutions?post=39724"},{"taxonomy":"tax_location_states","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tax_location_states?post=39724"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}